Search keyWord :

FinVolution Group Reports Third Quarter 2024 Unaudited Financial Results

Nov 19, 2024

-Third Quarter Total Transaction Volume reached RMB52.2 billion,up 1.8% year-over-year- -Third Quarter International Transaction Volume reached RMB2.7 billion,up 22.7% year-over-year-

Achyuta Samanta Honoured With FIVB Grand Cross Award

Nov 19, 2024

BHUBANESWAR,India,Nov. 19,2024-- The Founder of KIIT and KISS,has been conferred the prestigious \'Grand Cross Award\',the highest honour from the International Volleyball Federation (FIVB). This re

Supermicro Delivers Direct-Liquid-Optimized NVIDIA Blackwell Solutions

Nov 19, 2024

Supermicro\'s SuperClusters with NVIDIA HGXTM B200 8-GPU,NVIDIA GB200,NVL4,and NVL72 Systems Deliver Unprecedented AI Compute Density

BLUETTI and UN-Habitat Forge Partnership to Promote Clean Energy and Sustainable Development Across Africa

Nov 19, 2024

LAS VEGAS,Nov. 19,2024-- BLUETTI,a global leader in clean energy storage solutions,has entered into a strategic partnership with the United Nations Human Settlements Programme (UN-Habitat) at the 12t

Tuya Reports Third Quarter 2024 Unaudited Financial Results

Nov 19, 2024

SANTA CLARA,Calif.,Nov. 19,2024-- Tuya Inc. ("Tuya" or the "Company") (NYSE: TUYA; HKEX: 2391),a global leading cloud platform service provider,today announced its unaudited financ

TCL CSOT Unveils APEX: An Advanced Display Technology Brand to Redefine Visual Experience

Nov 19, 2024

GUANGZHOU,China,Nov. 19,2024-- TCL CSOT,a global leader in display technology,has officially launched APEX,its advanced display technology brand,at the 2024 TCL CSOT Global Display Tech-ecosystem Conf

Celltrion presents additional data from phase III randomized controlled trials to further support biosimilarity for CT-41 (biosimilar candidate of denosumab) and CT-P47 (biosimilar candidate of tocilizumab) at American College of Rheumatology (ACR) Conver

Nov 19, 2024

78-Week results from Phase III randomized controlled trial (RCT) including switching data from reference denosumab to CT-P41 (biosimilar candidate of denosumab) demonstrate comparable efficacy and sa

Trip.com Group Limited Reports Unaudited Third Quarter of 2024 Financial Results

Nov 19, 2024

SINGAPORE,Nov. 19,2024-- Trip.com Group Limited (Nasdaq: TCOM; HKEX: 9961) ("Trip.com Group" or the "Company"),a leading one-stop travel service provider of accommodation reservati

TCL CSOT Announces the Mass Production of Inkjet Printing OLED at DTC2024

Nov 19, 2024

GUANGZHOU,China,Nov. 19,2024-- On November 16th,the 2024TCL CSOT Global Display Tech-ecosystem Conference (DTC2024) kicked off with great fanfare. The conference brought together global display indust

Waterdrop Filter's Black Friday Starts from November 18: Upgrade Your Home Hydration for the Holidays and Beyond

Nov 19, 2024

LOS ANGELES,Nov. 19,2024-- As the holiday season approaches and winter chills set in,Waterdrop Filter,the leading innovator in water filtration,is making this Black Friday the perfect time to upgrade

1 ... 779 780 781 782 783 784 785 ... 1285